You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Ammonia N-13

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ammonia N-13 Myocardial Blood Flow Absolute Quantification by

Recruiting
  • Myocardial Ischemia
  • +7 more
  • Myocardial Perfusion Imaging Study
  • AMMONIA N-13 37.5 mCi in 1 mL INTRAVENOUS INJECTION [Ammonia N 13]
  • Miami, Florida
  • +3 more
Jan 4, 2023

N-13 Ammonia Safety Trial in Montréal (N-13 ammonia intravenous injection)

Recruiting
  • N-13 Ammonia Safety
  • N-13 ammonia intravenous injection
  • Montréal, Quebec, Canada
    Centre Hospitalier de l'université de Montréal
Aug 5, 2022

Sickle Cell Disease Trial in Memphis ([13N]NH3, Lexiscan, Positron emission tomography)

Not yet recruiting
  • Sickle Cell Disease
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Jan 11, 2023

Biomarkers of Risk of Parkinson Disease

Active, not recruiting
  • Parkinson Disease
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 13, 2023

Quantitative 13N-Ammonia Cardiac Rest/Stress Digital PET/CT

Completed
  • Coronary Artery Disease
  • Cardiac Perfusion Rest/Stress Digital PET/CT
  • +2 more
  • Stanford, California
    Stanford University
Oct 24, 2021

Coronary Artery Disease Trial in Saint Louis (Ga-68 Galmydar, 13N-ammonia)

Recruiting
  • Coronary Artery Disease
  • Saint Louis, Missouri
    Washington University School of Medicine
Nov 20, 2022

Amyloidosis, Primary, Cardiomyopathy Trial in Boston (F-18 florbetapir/C-11 acetate PET, MRI, N-13 ammonia PET)

Recruiting
  • Amyloidosis, Primary
  • Cardiomyopathy
  • F-18 florbetapir/C-11 acetate PET
  • +2 more
  • Boston, Massachusetts
    Brigham and Womens' Hospital
Oct 23, 2022

Myocardial Infarction, Coronary Microvascular Dysfunction, Vasospasm, Coronary Trial in Gwangju (Intravascular imaging (OCT),

Recruiting
  • Myocardial Infarction
  • +2 more
  • Intravascular imaging (OCT), Invasive physiologic assessment (FFR, CFR, IMR), or Non-invasive physiologic assessment (N-13 ammonia PET)
  • Gwangju, Korea, Republic of
    Chonnam National University Hospital
Mar 13, 2022

Chronic Right-Sided Heart Failure, Pulmonary Arterial Hypertension, Pulmonary Hypertension, Primary, 2 Trial in Ottawa (drug,

Recruiting
  • Chronic Right-Sided Heart Failure
  • +5 more
  • Ottawa, Ontario, Canada
    University of Ottawa Heart Institute
Nov 19, 2021

Microvascular Coronary Artery Disease Trial in Worldwide (SAR407899, Placebo, Adenosine)

Terminated
Has Results
  • Microvascular Coronary Artery Disease
  • Los Angeles, California
  • +9 more
Mar 15, 2022

Coronary Disease Trial in Beijing (18F-FMPP)

Unknown status
  • Coronary Disease
  • Beijing, Dongcheng, China
    Peking union medical college hospital
Oct 21, 2020

Liver Tumor, Liver Tumors Trial in Boston (N-13 ammonia or F-18 fluorodeoxyglucose, PET scan)

Completed
Has Results
  • Liver Tumor
  • Liver Neoplasms
  • N-13 ammonia or F-18 fluorodeoxyglucose
  • PET scan
  • Boston, Massachusetts
  • +1 more
Mar 4, 2020

Benign Kidney Tumor, Kidney Tumor, Renal Cell Cancer Trial in San Francisco (Hyperpolarized Carbon C 13 Pyruvate, Magnetic

Recruiting
  • Benign Kidney Neoplasm
  • +2 more
  • Hyperpolarized Carbon C 13 Pyruvate
  • +2 more
  • San Francisco, California
    University of California, San Francisco
Jan 6, 2023

Chronic Inflammation on Myocardial Perfusion and Function

Completed
  • Psoriasis
  • 13N Amonia
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 24, 2023

Prostate Cancer Trial in Toronto (Hyperpolarized Pyruvate (13C))

Recruiting
  • Prostate Cancer
  • Hyperpolarized Pyruvate (13C)
  • Toronto, Ontario, Canada
    Sunnybrook Health Sciences Centre
May 4, 2022

MDD Trial in Manchester, Liverpool (SPL026)

Recruiting
  • Major Depressive Disorder
  • Manchester, Greater Manchester, United Kingdom
  • +1 more
Jan 18, 2023

Acute Coronary Syndrome Trial (index of microcirculatory resistance)

Completed
  • Acute Coronary Syndrome
  • index of microcirculatory resistance
  • (no location specified)
Nov 17, 2019

Learning and Memory in Healthy Individuals and Those With Psychiatric Illness Trial in Chicago (GLYX-13, Placebo)

Terminated
  • Learning and Memory in Healthy Individuals and Those With Psychiatric Illness
  • Chicago, Illinois
    Northwestern University
Jan 14, 2022

Uterine Cervical Tumors Trial in Toronto (Hyperpolarized 13C-Pyruvate, 18F-FDG)

Terminated
  • Uterine Cervical Neoplasms
  • Toronto, Ontario, Canada
    Sunnybrook Health Sciences Centre
Sep 20, 2022

Total-body 13N-NH3 PET/CT to Study Blood Perfusion in Whole Body

Recruiting
  • Cardiac Output
  • total-body PET/CT(uEXPLORER , United Imaging Healthcare, China)
  • Shanghai, Shanghai, China
    Shanghai jiaotong University School of Medicine, Renji Hospital
Sep 24, 2021

Prostate Cancer Trial in San Francisco (Pyruvate (13C), Hyperpolarized 13C,15N2-urea, Magnetic Resonance Spectroscopic Imaging)

Active, not recruiting
  • Prostate Cancer
  • Pyruvate (13C)
  • +2 more
  • San Francisco, California
    University of California, San Francisco
May 16, 2022

Brain Metastases Trial in Toronto (Hyperpolarized 13C-Pyruvate)

Recruiting
  • Brain Metastases
  • Hyperpolarized 13C-Pyruvate
  • Toronto, Ontario, Canada
    Sunnybrook Health Sciences Centre
May 4, 2022

Chronic Liver Disease, Hepatocellular Carcinoma (HCC) Trial in Toronto (13C Sodium Octanoate)

Terminated
Has Results
  • Chronic Liver Disease
  • Hepatocellular Carcinoma (HCC)
  • 13C Sodium Octanoate
  • Toronto, Ontario, Canada
    Toronto General Hospital
Dec 19, 2022

Uncommon Presentations and/or Uncommon Diseases Associated With

Recruiting
  • Cardiomyopathy
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Smoking, Tobacco Use, Tobacco Smoking Trial in Lexington, Knoxville (Product A, Product B, Product C)

Completed
  • Smoking
  • +2 more
  • Product A
  • +5 more
  • Lexington, Kentucky
  • +1 more
Jun 23, 2022